These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 9154279

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effect of prostaglandin F2 alpha-1-isopropylester (PGF2 alpha-IE) on uveoscleral outflow.
    Nilsson SF, Sperber GO, Bill A.
    Prog Clin Biol Res; 1989; 312():429-36. PubMed ID: 2678148
    [Abstract] [Full Text] [Related]

  • 5. The uveoscleral outflow routes.
    Nilsson SF.
    Eye (Lond); 1997; 11 ( Pt 2)():149-54. PubMed ID: 9349404
    [Abstract] [Full Text] [Related]

  • 6. Initial clinical studies with prostaglandins and their analogues.
    Camras CB, Alm A.
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S61-8. PubMed ID: 9154278
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes.
    Toris CB, Camras CB, Yablonski ME.
    Ophthalmology; 1993 Sep; 100(9):1297-304. PubMed ID: 8371915
    [Abstract] [Full Text] [Related]

  • 9. Eicosanoids as a new class of ocular hypotensive agents. 2. Comparison of the apparent mechanism of the ocular hypotensive effects of A and F type prostaglandins.
    Hayashi M, Yablonski ME, Bito LZ.
    Invest Ophthalmol Vis Sci; 1987 Oct; 28(10):1639-43. PubMed ID: 3654137
    [Abstract] [Full Text] [Related]

  • 10. The effect of topical PGF2 alpha on uveoscleral outflow and outflow facility in the rabbit eye.
    Poyer JF, Gabelt B, Kaufman PL.
    Exp Eye Res; 1992 Feb; 54(2):277-83. PubMed ID: 1559555
    [Abstract] [Full Text] [Related]

  • 11. Effects of topical nipradilol, a beta-blocking agent with alpha-blocking and nitroglycerin-like activities, on aqueous humor dynamics and fundus circulation.
    Kanno M, Araie M, Tomita K, Sawanobori K.
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):736-43. PubMed ID: 9538880
    [Abstract] [Full Text] [Related]

  • 12. Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment.
    Stjernschantz J, Selén G, Astin M, Resul B.
    Prog Retin Eye Res; 2000 Jul; 19(4):459-96. PubMed ID: 10785618
    [Abstract] [Full Text] [Related]

  • 13. The effects of prostaglandins on the blood-ocular barrier.
    Kosaka T, Mishima HK, Kiuchi Y, Kataoka K.
    Jpn J Ophthalmol; 1995 Jul; 39(4):368-76. PubMed ID: 8926644
    [Abstract] [Full Text] [Related]

  • 14. Effects of prostaglandins on the aqueous humor outflow pathways.
    Weinreb RN, Toris CB, Gabelt BT, Lindsey JD, Kaufman PL.
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S53-64. PubMed ID: 12204701
    [Abstract] [Full Text] [Related]

  • 15. The influence of Latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study.
    Dinslage S, Hueber A, Diestelhorst M, Krieglstein G.
    Graefes Arch Clin Exp Ophthalmol; 2004 Aug; 242(8):654-60. PubMed ID: 15241610
    [Abstract] [Full Text] [Related]

  • 16. Effects of topical PGF2 alpha on aqueous humor dynamics in cynomolgus monkeys.
    Crawford K, Kaufman PL, Gabelt BT.
    Curr Eye Res; 1987 Aug; 6(8):1035-44. PubMed ID: 3478175
    [Abstract] [Full Text] [Related]

  • 17. Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha-1-isopropylester in the cynomolgus monkey.
    Nilsson SF, Samuelsson M, Bill A, Stjernschantz J.
    Exp Eye Res; 1989 May; 48(5):707-16. PubMed ID: 2737263
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treatment.
    Johnson TV, Fan S, Zhan G, Camras CB, Toris CB.
    J Glaucoma; 2010 Aug; 19(6):356-64. PubMed ID: 20179619
    [Abstract] [Full Text] [Related]

  • 19. [Pharmacological profiles of latanoprost (Xalatan), a novel anti-glaucoma drug].
    Nomura S, Hashimoto M.
    Nihon Yakurigaku Zasshi; 2000 May; 115(5):280-6. PubMed ID: 10872179
    [Abstract] [Full Text] [Related]

  • 20. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes.
    Ziai N, Dolan JW, Kacere RD, Brubaker RF.
    Arch Ophthalmol; 1993 Oct; 111(10):1351-8. PubMed ID: 8216015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.